Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The global cellular antioxidant defense system is a multi-layered network of enzymes and small molecules dedicated to maintaining redox homeostasis by neutralizing reactive oxygen species (ROS) (Source: NIH, PubMed). This system includes primary enzymes such as superoxide dismutase (SOD), catalase, and glutathione peroxidase, which sequentially convert toxic radicals into harmless water and oxygen (Source: StatPearls). It is largely regulated by the transcription factor Nrf2, which translocates to the nucleus under oxidative stress to activate the expression of antioxidant response element (ARE)-containing genes (Source: Nature Reviews Drug Discovery). Dysregulation of this system leads to oxidative stress, a condition implicated in the pathogenesis of cancer, neurodegeneration, and cardiovascular diseases due to cumulative damage to DNA, lipids, and proteins (Source: Wikipedia, PubMed). Pharmacological intervention typically aims to bolster these defenses using Nrf2 activators like dimethyl fumarate or glutathione precursors like N-acetylcysteine (Source: PubChem). However, therapeutic modulation is challenging because ROS also function as vital signaling molecules for cell proliferation and immune defense; thus, excessive antioxidant activity can lead to "reductive stress" (Source: Cell Metabolism). Furthermore, in the context of oncology, an overactive antioxidant system can protect tumor cells from the oxidative damage induced by chemotherapy and radiotherapy (Source: PubMed).
The system functions through the enzymatic neutralization of reactive oxygen species, the induction of cytoprotective genes via the Nrf2-ARE signaling pathway, and the maintenance of a reduced cellular environment through high concentrations of non-enzymatic antioxidants like glutathione.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Global cellular antioxidant defense system (ROS defense system).